| Title : p21-activated kinase 4 counteracts PKA-dependent lipolysis by phosphorylating FABP4 and HSL - Yu_2024_Nat.Metab__ |
| Author(s) : Yu HC , Jeon YG , Na AY , Han CY , Lee MR , Yang JD , Son JB , Kim ND , Kim JB , Lee S , Bae EJ , Park BH |
| Ref : Nat Metab , : , 2024 |
| Abstract : |
| PubMedSearch : Yu_2024_Nat.Metab__ |
| PubMedID: 38216738 |
| Title : p21-activated kinase 4 counteracts PKA-dependent lipolysis by phosphorylating FABP4 and HSL - Yu_2024_Nat.Metab__ |
| Author(s) : Yu HC , Jeon YG , Na AY , Han CY , Lee MR , Yang JD , Son JB , Kim ND , Kim JB , Lee S , Bae EJ , Park BH |
| Ref : Nat Metab , : , 2024 |
| Abstract : |
| PubMedSearch : Yu_2024_Nat.Metab__ |
| PubMedID: 38216738 |
| Title : p21-activated kinase 4 counteracts PKA-dependent lipolysis by phosphorylating FABP4 and HSL - Yu_2024_Nat.Metab__ |
| Author(s) : Yu HC , Jeon YG , Na AY , Han CY , Lee MR , Yang JD , Son JB , Kim ND , Kim JB , Lee S , Bae EJ , Park BH |
| Ref : Nat Metab , : , 2024 |
| Abstract : |
| PubMedSearch : Yu_2024_Nat.Metab__ |
| PubMedID: 38216738 |
| Title : Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes - Kim_2016_Eur.J.Pharmacol_771_65 |
| Author(s) : Kim TH , Kim MK , Cheong YH , Chae YN , Lee Y , Ka SO , Jung IH , Shin CY , Bae EJ , Son MH |
| Ref : European Journal of Pharmacology , 771 :65 , 2016 |
| Abstract : |
| PubMedSearch : Kim_2016_Eur.J.Pharmacol_771_65 |
| PubMedID: 26621343 |
| Title : Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes - Kim_2016_Eur.J.Pharmacol_771_65 |
| Author(s) : Kim TH , Kim MK , Cheong YH , Chae YN , Lee Y , Ka SO , Jung IH , Shin CY , Bae EJ , Son MH |
| Ref : European Journal of Pharmacology , 771 :65 , 2016 |
| Abstract : |
| PubMedSearch : Kim_2016_Eur.J.Pharmacol_771_65 |
| PubMedID: 26621343 |
| Title : Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes - Kim_2016_Eur.J.Pharmacol_771_65 |
| Author(s) : Kim TH , Kim MK , Cheong YH , Chae YN , Lee Y , Ka SO , Jung IH , Shin CY , Bae EJ , Son MH |
| Ref : European Journal of Pharmacology , 771 :65 , 2016 |
| Abstract : |
| PubMedSearch : Kim_2016_Eur.J.Pharmacol_771_65 |
| PubMedID: 26621343 |